30 Technology Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $32.5M

  • Investors
  • 6

30 Technology General Information

Description

Developer of a biopharmaceutical platform designed to improve the lives of patients suffering from serious and life-threatening medical conditions. The company's platform helps to develop and define new models of care by unlocking the potential of nitric oxide to treat a host of serious medical conditions, enabling healthcare professionals to develop treatments to enhance patients' healing conditions and defense mechanisms.

Contact Information

Website
www.30.technology
Formerly Known As
EdixoMed, Thirty Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Red Place
  • London W1K 6PL
  • England, United Kingdom
+44 01235
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 1 Red Place
  • London W1K 6PL
  • England, United Kingdom
+44 01235

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

30 Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Nov-2018 $32.5M Completed Pre-Clinical Trials
7. Later Stage VC 25-Mar-2015 Completed Pre-Clinical Trials
6. Grant 01-Feb-2015 Completed Pre-Clinical Trials
5. Grant 01-Feb-2013 Completed Pre-Clinical Trials
4. Grant 01-Jun-2012 Completed Pre-Clinical Trials
3. Early Stage VC 18-Apr-2012 Completed Pre-Clinical Trials
2. Grant 01-Jul-2011 $400K $653K Completed Pre-Clinical Trials
1. Seed Round 01-Mar-2010 $653K $653K Completed Pre-Clinical Trials
To view 30 Technology’s complete valuation and funding history, request access »

30 Technology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view 30 Technology’s complete cap table history, request access »

30 Technology Patents

  • 37

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

30 Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202413854-D0 Compositions and kits for generating nitric oxide Pending 20-Sep-2024
GB-202302119-D0 Wound dressings Inactive 14-Feb-2023
GB-202215758-D0 Implantable medical devices Pending 25-Oct-2022
GB-202215521-D0 Wound dressings Pending 20-Oct-2022
GB-202005980-D0 Methods and compositions for generating nitric oxide and uses thereof Inactive 23-Apr-2020
To view 30 Technology’s complete patent history, request access »

30 Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

30 Technology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morningside Group Venture Capital Minority
Barts Charity University
Medical Research Council VC-Backed Company
Scottish Enterprise Government Minority
Small Business Research Initiative Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

30 Technology FAQs

  • When was 30 Technology founded?

    30 Technology was founded in 2009.

  • Where is 30 Technology headquartered?

    30 Technology is headquartered in London, United Kingdom.

  • What is the size of 30 Technology?

    30 Technology has 20 total employees.

  • What industry is 30 Technology in?

    30 Technology’s primary industry is Drug Discovery.

  • Is 30 Technology a private or public company?

    30 Technology is a Private company.

  • What is 30 Technology’s current revenue?

    The current revenue for 30 Technology is .

  • How much funding has 30 Technology raised over time?

    30 Technology has raised $40.5M.

  • Who are 30 Technology’s investors?

    Morningside Group, Barts Charity, Medical Research Council, Scottish Enterprise, and Small Business Research Initiative are 5 of 6 investors who have invested in 30 Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »